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by the C/EBPb diﬁciency in the chondrocytes. p57 was co-localized with
C/EBPb in late proliferative and pre-hypertrophic chondrocytes of the
growth plate, which was dramatically decreased by the C/EBPb deﬁciency.
The promoter activity of p57 was enhanced by C/EBPb transfection.
Deletion, mutagenesis, and tandem-repeat analyses of the luciferase
assay identiﬁed the core responsive element to be between the −150
and −130 bp region containing a putative C/EBP-binding motif. EMSA
revealed the binding of C/EBPb-overexpressed nuclear extracts with the
oligonucleotide including this region, whose speciﬁcity was veriﬁed by the
C/EBPb antibody supershift. The knockdown of p57 by the siRNA inhib-
ited the C/EBPb-induced hypertrophic differentiation in cultured chondro-
cytes.
Conclusions: C/EBPb directly transactivates p57 at a speciﬁc C/EBP
motif to promote transition from proliferation to hypertrophic differentiation
of chondrocytes during skeletal growth, indicating the essential role of the
C/EBPb/p57 signal during endochondral ossiﬁcation.
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Purpose: Mitochondria are involved in many cellular processes, and
mitochondrial dysfunctions have been associated with apoptosis, aging
and a number of pathological conditions, including osteoarthritis (OA).
Therefore, mitochondrial proteins are an attractive target to study the
metabolism of chondrocyte and its role in cartilage degradation. We
aimed in this work to analyze the mitochondrial protein changes that
are characteristic of OA chondrocytes, and identify a new OA-related
mitochondrial protein proﬁle.
Methods: Chondrocytes were obtained from OA patients undergoing
joint replacement, and cartilages from autopsies without history of joint
disease. Mitochondria were isolated by differential centrifugation pro-
cesses. Protein proﬁling was carried out using the differential in-gel
electrophoresis technology (DIGE). Brieﬂy, mitochondrial proteins from
control and OA samples were labelled with different ﬂuorescent dyes and
co-resolved by 2D gel electrophoresis using a pool of all samples as
internal standard. Biological variation analysis, statistics and hierarchical
clustering were performed using DeCyder software. OA-related proteins
were identiﬁed by MALDI-TOF/TOF mass spectrometry. Validation of
the results was carried out by real-time PCR, Western blotting and
immunoﬂuorescence analyses. Pathway analysis was performed using
PathwayStudio software.
Results: We examined more than 1500 protein spots that were present
in the six different DIGE gels. Both qualitative and quantitative changes
in protein abundance patterns were studied, considering changes within
95% conﬁdence interval and standardized average ratios exceeding 1.3
in at least four of the six analyzed gels. 28 protein spots were found
to be increased in OA cells, including the TNFa-receptor-associated
protein and two subunits of the mitochondrial respiratory chain com-
plex I. On the other hand, 45 protein spots were decreased in OA
chondrocytes, including two mitoﬁlin and two mitochondrial superoxide
dismutase (MnSOD, ratio −1.6, p =0.0024) forms. Unsupervised Princi-
pal Component Analysis and hierarchical clustering (HCA) of these 73
differentially present proteins – 22 of them which were previously deﬁned
as mitochondrial (Figure 1) – allowed the deﬁnition of two different protein
proﬁles corresponding to OA and control samples. Network analysis
was accomplished to evaluate the biological functions affected by this
chondrocyte mitochondrial dysregulation in OA. Validation of the results
was performed for MnSOD by western blot and real time PCR on OA
and normal chondrocyte protein extracts. We also found MnSOD protein
levels signiﬁcantly decreased in osteoarthritic cartilage superﬁcial layer
when compared to control.
Conclusions: This study describes the differences between the mito-
chondrial protein proﬁles of normal and OA chondrocytes, evidencing the
mitochondrial dysregulation that takes place during cartilage degradation
in osteoarthritis. Reduction of MnSOD in OA chondrocytes suggests a
decreased antioxidant activity of cartilage cells that might contribute to
tissue degradation.
Figure 1. Mitochondrial proteins altered in OA. A: Proteome map indi-
cating those mitochondrial proteins that exhibit differences in abundance
when compared to control. B: Unsupervised hierarchical clustering of
the 22 identiﬁed mitochondrial proteins, indicating the variations in abun-
dance.
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Purpose: Evidence suggests that cell aging or senescence is impor-
tant in the pathogenesis of osteoarthritis (OA). Indeed, by analogy to
neurodegenerative disorders, OA has been termed by Aigner as the
“M. Alzheimer” of articular cartilage. In certain forms of progeria, a defect
in lamin A processing leads to accelerated aging of mesenchymal tissues,
and development of OA at a very young age. In the current study, we
report that OA chondrocytes accumulate lamin A, leading to activation of
caspase 3 and mitochondrial dysfunction.
Methods: Human OA cartilage samples and chondrocytes were isolated
from patients undergoing knee replacement surgery as approved by IRB.
Standard Western Blot, ﬂuorescent microscopy, and Q-PCR techniques
were used. Anti-human lamin A antibody was purchased from Abcam
Inc. TUNEL staining (Roche), ATP Bioluminescence assays (Sigma), and
activated caspase 3 assays (R&D) were performed per manufacturer’s
recommendations.
Results: Lamin A expression was markedly increased (immuno blot) in
chondrocytes derived from OA cartilage samples (n = 6) when compared
with age matched healthy controls (n = 4). Q-PCR analysis demonstrated
a signiﬁcant increase in the Lamin A: Lamin B mRNA ratio in the OA
samples (2.9±0.4 in healthy controls vs. 7.2±1.7 in OA subjects). Since
Il-1b and PGE2 are catabolic mediators, which have been shown to
promote apoptosis in OA chondrocytes, we explored their effects on lamin
A expression. Il-1b caused little to no change in lamin A expression. In
contrast the exposure of chondrocytes to PGE2 (10 uM) caused a marked
increased lamin A accumulation (Western blot) in a rimmed pattern
around the nucleus (confocal microscopy), as well as an increase in
lamin A:lamin B mRNA ration (Q-PCR). This pattern of increased protein
expression and lamin A:lamin B mRNA mimicked that observed in OA
cartilage, suggesting that PGE2 augments lamin A expression via post-
translational mechanisms. These effects by exogenous PGE2 on lamin A
expression were blocked by antagonists of the EP2 receptor, but not
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the EP4 receptor. To determine the effects of lamin A overexpression
on chondrocytes, we transfected human chondrocyte cell lines (HTB94
and C28/I2) with wild-type or progerin-type lamin A protein. Transfected
cells displayed markers of early apoptosis, including increased caspase-3
activity decreased cytoplasmic ATP levels loss of mitochondrial mem-
brane potential (JC1 staining), and decreased bcl2 transcription when
compared to mock plasmid transfected controls. Surprisingly, we did not
detect markers of advanced apoptosis in the transfected cells (TUNEL by
microscopy, DNA laddering, PI staining by FACS), suggesting that lamin
A induces cellular injury that initiates but does not complete programmed
cell death.
Conclusions: This study demonstrates that the progeria-associated pro-
tein lamin A is upregulated in OA chondrocytes, where it leads to cellular
changes characteristic of early apoptosis. We suggest that nuclear accu-
mulation of lamin A in response to catabolic stress may account for the
premature aging phenotype and senescence of OA chondrocytes.
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Purpose: Congenital dysplasia of the hip (CDH) is an abnormality of the
seating of the femoral head in the acetabulum, mainly caused by Shallow
acetabulum and lax capsule. CHD is the most prevalent causative factor of
secondary hip OA. Genetic factors are considered to play a considerable
role in pathogenesis of CDH. GDF5 has been identiﬁed being involved in
skeletal development and joint morphogenesis in humans and mice, play-
ing a crucial role in the morphogenesis of tendons, ligaments and bones.
Recently a functional single nucleotide polymorphism (SNP) (rs143383,
T/C) in the 5’-UTR of the growth differentiate factor 5 (GDF5) gene
was reported associated with osteoarthritis (OA) susceptibility. Function
study showed that allele T of rs143383 mediates a signiﬁcant reduction
of promoter activity in GDF5 gene. As a key role in morphogenesis of
skeletal components and soft tissues in and around joints, GDF5 may be
involved in the pathogenesis of CDH. To investigate this association, a
case-control study was conducted.
Methods: The GDF5 SNP rs143383 was genotyped in 338 children who
suffered from CDH disease with radiographic conﬁrmation and 622 control
subjects using Taqman assay (7500 Real Time PCR System, Applied
Biosystems).
Results: GDF5 was signiﬁcantly associated with CDH (P =0.0037;
OR=1.40; 95%CI = 1.11−1.75). Signiﬁcant difference was detected in
female samples when stratiﬁed by gender (P =0.0053; OR=1.46;
95%CI = 1.21−1.91), and when stratiﬁed by severity (P =0.0058;
OR=1.43; 95%CI = 1.11−1.85).
Conclusions: Our results indicate that GDF5 is important in the etiology
of CDH. This was the ﬁrst the deﬁnite instance that association of the
CDH susceptibility was detected.
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Purpose: The etiology of Osteoarthritis (OA) is still unclear partly due
to the many biomechanical and molecular factors associated with the
development of OA. One of these biomechanical factors is the practice
of sports among which soccer is considered one of the most harmful.
The high risk for OA among professional soccer players might be caused
by a deformation of the femoral head called cam impingement, a type
of femoroacetabular impingement. This deformity would occur during
adolescence after a long period of excessive sports practice caused
by a slipped capital femoral epiphysis. Cam impingement comprises a
shortening of the collum femoris and a ﬂattening of the concave surface
of the lateral part of the femoral head. In cam impingement the femoral
head impinges on the anterior acetabulum and thereby damages the
labrum.
We investigated whether anatomical variations resembling cam impinge-
ment occur more often among active soccer players than in a general
population and if these anatomical variations are associated with OA. The
anatomical variations were quantiﬁed using a Statistical Shape Model of
the proximal femur.
Methods: A Statistical Shape Model (SSM) was created of the shape of
the proximal femur and acetabulum in anterior-posterior x-ray images of
the hips. The method results in a set of independent modes that together
quantitatively describe the total shape, while each mode separately
describes a speciﬁc characteristic of the shape.
The SSM comprised 83 x-rays of retired soccer players and 51 x-rays of
male controls that were taken from the GOAL cohort. GOAL consists of
patients with complaints of the hip that were included on their ﬁrst visit
to the physician. The control group and the retired soccer players had
similar age, weight and OA levels as measured by Kellgren & Lawrence
scores.
Regression analysis was used to test differences between the groups and
the effect of OA (deﬁned as K&L> 1) on each shape aspect.
Results: We did not ﬁnd any striking differences between the general
shape of retired soccer players and the control group.
Subjects with OA showed a signiﬁcantly different shape of the hip than
non-oa subjects, irrespective of group status (soccer player or control).
This difference was described and quantiﬁed by three distinct and inde-
pendent shape modes: At OA the femoral head was laterally extended
(mode 1); the transition from the superior part of the neck into the head
was more gradual (mode 2); and the joint space was narrower (mode 3).
Conclusions: One of the shape aspects (see ﬁgure) showed the lateral
extension of the femur typical for a cam type deformity. Interestingly,
this deformity was stronger in the subjects with OA, but similar between
soccer players and controls (see ﬁgure). Thus, the relation between cam
type impingement and OA does not seem to be speciﬁc for soccer players
but might be general in all OA populations.
In general, all shape aspects that related to the transition from neck to
head showed a relation with OA. Therefore, femoroacetabular impinge-
ment might indeed play a role in the development of OA, even if the
deformity is mild as is the case for non-clinical cases.
Cam type deformity, quantiﬁed in a statistical shape model.
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Purpose: To examine the difference in bone shape between non-
progressors and progressors, as determined by radiographic OA.
Methods: Radiographic OA progression was judged using a decrease
in the joint space width, measured at the central point of the medial
joint. KneeAnalyzer software (Optasia Medical, Manchester, UK) was
used to make semi-automated annotations of the radiographs. JSW was
automatically calculated along a parameterized line bisecting the medial
compartment, with its origin (x = 0) at the tip of the tibial spine and end
(x = 1) at the outer medial edge of the joint. The central JSW (cJSW)
was measured at x = 0.5 on this line. Calibration was made by automated
location of Synaﬂexer beads within the image.
Subjects with K-L scores of 2 or 3; medial JSN greater than lateral JSN,
and evidence of medial osteophytes were selected from the 12 months
OAI progression groups 0.B.1 and 1.B.1. Those with a reduction in cJSW
greater than 12% of baseline were classiﬁed as progressors (n = 15,
8 female). Subjects whose cJSW changed by 0±3% (n=15, 7 female)
were classiﬁed as non-progressors.
The bone shapes for each individual were determined by ﬁtting a 3D
statistical model of shape and intensity to the baseline image. Quality of
the ﬁtting was assessed visually and by comparison with manual markup.
